Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
29
ANTX Quote, Financials, Valuation and Earnings
Last price:
$1.38
Seasonality move
:
-47.68%
Day range:
$1.24 - $1.28
52-week range:
$0.87 - $22.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.43x
Volume:
113.2K
Avg. volume:
853.7K
1-year change:
-93.86%
Market cap:
$37.6M
Revenue:
--
EPS (TTM):
-$2.04
Earnings Data
Next earnings date for ANTX
Mar 28
2025
Most recent earnings per share
-$0.43
Missed by $0.04
(Nov 13/2024)
Consensus Estimate
-$0.39
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ANTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/28/2025 | Q4 | -- | -- | -- | -$0.26 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/13/2024 | Q2 | -- | -- | -$0.48 | -$0.59 | $0.11 |
| 05/14/2024 | Q1 | -- | -- | -$0.56 | -$0.62 | $0.06 |
| 03/28/2024 | Q4 | -- | -- | -$0.57 | -$0.75 | $0.18 |
| 11/09/2023 | Q3 | -- | -- | -$0.65 | -$0.63 | -$0.02 |
| 08/10/2023 | Q2 | -- | -- | -$0.81 | -$0.85 | $0.04 |
| 05/11/2023 | Q1 | -- | -- | -$0.79 | -$0.68 | -$0.11 |
| 03/29/2023 | Q4 | -- | -- | -$0.61 | -$0.65 | $0.04 |
| 11/09/2022 | Q3 | -- | -- | -$0.59 | -$0.60 | $0.01 |
| 08/11/2022 | Q2 | -- | -- | -$0.52 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$2.98 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.52 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$0.63 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.49 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -- | -- |
AN2 Therapeutics Earnings Questions
-
How Much did AN2 Therapeutics Generate in Revenue Last Quarter?
AN2 Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did AN2 Therapeutics Beat Earnings Last Quarter?
AN2 Therapeutics announced earnings per share of -$0.43 which represents a miss of analyst forecast a -$0.39 per share.
-
Is AN2 Therapeutics Profitable?
AN2 Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for AN2 Therapeutics EPS Next Year?
AN2 Therapeutics's earnings are forecast to decrease from -$2.74 per share to -$2.94 per share next year representing a decrease of -47.08%.
-
When is AN2 Therapeutics's Earnings Date?
AN2 Therapeutics's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 0.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 6.55% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.65% over the past day.
